The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been up 0.2% at around 8,195 points.

Neuren Pharmaceuticals (ASX:NEU) has been the most watched on HotCopper so far today, after reporting Q1 FY25 sales of its DAYBUE product increased by 11% to US$84.6 million over the corresponding period.

Neuren Pharmaceuticals has been $12.46.

Pointerra (ASX:3DP) has also been trending on news it has won a contract with the US Army to provide geospatial research to enhance the Army’s capabilities.

Pointerra has been 6.3 cents.

And, finally Locksley Resources (ASX:LKY) has made significant progress toward drilling approvals at its Desert Antimony Mine and has now formally submitted the drill permit application.

Locksley Resources has been 5.4 cents.

More From The Market Online

Nanoveu to expand drone capabilities with strategic Spinoff acquisition

Nanoveu is adding new drone technology through the proposed strategic acquisition of Singapore company Spinoff Robotics.

Archer Materials advances biosensor beta prototype and manufacturing pathway

Archer Materials has continued to progress toward development its biosensor beta prototype for blood potassium sensing.
Image of bear lifting weights

Week 20, Wrapped: XJO flounders as Brent still above $100/bbl; US hike hopes dampen gold & CBA misery

On Thursday, it looked like the ASX might have shaken off its week-long doldrums when we closed green.

Dateline Resources identifies underground gold potential upside at Colosseum

Dateline Resources has uncovered two new broad gold intersections with drill testing of the northeast extension…